Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roam Robotics
San Francisco, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Clinical studies show Ascend reduces knee pain by an average of 46% and provides functional improvement in 67% of users with knee osteoarthritis. It is FDA-registered as a Class I device and available for preorder or use in medical and research settings[4][6][7].
- Therapeutic areas
- NeurologyRheumatology
- Modalities
- DeviceWearable roboticsNon-pharmacological therapy
- Industry
- Assistive Medical Devices
02
Partnerships
San Francisco VA Health Care SystemNorthern California Institute for Research and Education (NCIRE)
Beyond the preview
Go deeper on Roam Robotics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Roam Robotics.